14:25 EDT U.S. files False Claims Act complaint against Elevance, Humana (HUM), Aetna
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Elevance Health price target raised to $465 from $450 at Argus
- Elevance Health’s Strong Q1 2025 Performance and Diverse Revenue Streams Justify Buy Rating
- ‘Medicaid to the Rescue,’ Says Wall St. Analyst About Elevance Health (ELV) Stock
- Elevance Health’s Growth Potential Justifies Buy Rating Amid Sector Challenges
- Buy Rating for Elevance Health: Stable Medicaid and Medicare Advantage Outlook with Potential Upside
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue